Comparison of multiHance® and Gadovist® for cerebral MR perfusion imaging in healthy volunteers;Vergleich von multiHance® und Gadovist® zur zerebralen MR-perfusionsmessung bei gesunden probanden

Radiologe

Volumn 42, Issue 11, 2002, Pages 909-915

  Essig, M ^a   Lodemann, K P ^b   LeHuu, M ^a   Schonberg S O ^c   Hubener M ^a   Van Kaick, G ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Bracco Byk Gulden ^*  (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cerebral blood flow (CBF); Cerebral blood volume (CBV); Contrast media; Magnetic resonance imaging; Perfusion

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBUTROL; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOBENIC ACID; GADOLINIUM DO3A BUTRIOL; GADOLINIUM-DO3A-BUTRIOL; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; BRAIN PERFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; GRAY MATTER; HUMAN; IMAGE QUALITY; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; WHITE MATTER; BLOOD FLOW; BLOOD FLOW VELOCITY; BRAIN; COMPARATIVE STUDY; EVALUATION; IMAGE ENHANCEMENT; METHODOLOGY; PHASE 1 CLINICAL TRIAL; PHYSIOLOGY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; VASCULARIZATION;

ADULT; BLOOD FLOW VELOCITY; BRAIN; CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; REFERENCE VALUES; REGIONAL BLOOD FLOW; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD;

EID: 0036836294     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-002-0819-x     Document Type: Article

References (20)

1. Heiland S, Sartor K (1999) Magnetic resonance tomography in stroke - its methodological bases and clinical use. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 171:3-14
2. Knopp EA, Cha S, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff II (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791-798
3. Klose J, Nägele T, Friese S, Bitzer M (1999) The characteristic values in the MR study of cerebral blood flow with high spatial and temporal resolution. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 170:474-481
4. Zierler KL (1962) Circulation times and the theory of indicator-dilution methods for determining blood flow and volume. In: Handbook of physiology. Williams & Wilkins, Baltimore, pp 585-615
5. Rempp KA, Brix G, Wenz F, Becker CR, Gückel F, Lorenz WJ (1994) Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 193:637-641
6. Østergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 36:726-736
7. Scholdei R, Wenz F, Essig M, Fuss M, Knopp MV (1999) Simultane Bestimmung der arteriellen Inputfunktion für die dynamische Suszeptibilitätsgewichtete Magnetresonanztomographie aus der A. carotis interna und der A. cerebri media. Fortschr Röntgenstr 171:38-43
8. Benner T, Heiland S, Erb G, Forsting M, Sartor K (1997) Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast enhanced MRI: influence of time resolution, maximal signal drop and signal-to-noise. Magn Reson Imaging 15:307-317
9. Benner T, Reimer P, Erb G, Schuierer G, Heiland S, Fischer C, Geens V, Sartor K, Forsting M (2000) Cerebral MR perfusion imaging: first clinical application of a 1 M gadolinium chelate (Gadovist 1.0) in a double-blinded randomized dose-finding study. J Magn Reson Imaging 12:371-380
10. Essig M, Hartmann M, Lodemann KP, Jansen O, Runge V, Knopp MV (2001) Vergleich des Kontrastverhaltens von Gd-BOPTA und Gd-DTPA bei intraaxialen Hirntumoren: Eine doppelblinde randomisierte intraindividuelle Vergleichsstudie. Radiologe 41:1063-1071
11. Cavagna FM, Maggioni F, Castelli PM et al. (1997) Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 32:780-796
12. Jansen O, Heiland S, Schellinger P (1998) Neuroradiologic diagnosis in acute arterial cerebral infarct. Current status of new methods. Nervenarzt 69:465-471
13. Bruning R, Weber J, Wu RH, Kwong KK, Hennig J, Reiser M (1995) Echo-planar imaging of the brain. Radiologe 35:902-910
14. Bozzao A, Floris R, Baviera ME, Apruzzese A, Simonetti G (2001) Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. AJNR Am J Neuroradiol 22:1030-1036
15. Kostler H, Becker H (2001) Quantitative multi-slice imaging of perfusion of the brain. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 173:18-23
16. Kucharczyk J, Asgari H, Mintorovitch J et al. (1993) Cerebrovascular transit characteristics of DyDTPA-BMA and GdDTPA-BMA on normal and ischemic cat brain. AJNR Am J Neuroradiol 14:289-296
17. Runge VM, Kirsch JE, Wells JW, Wollfolk CE (1993) Assessment of cerebral perfusion by first-pass, dyna mic, contrast-enhanced, steady-state free-precession MR imaging: an animal study. AJR Am J Roentgenol 160:593-600
18. Essig M, Schoenberg SO, Schlemmer HP, Metzner R, van Kaick G (2000) Funktionelle Magnetresonanztomographie in der Neuroradiologie. Radiologe 40:849-857
19. Heiland S, Reith W, Forsting M, Sartor K (2001) How do concentration and dosage of the contrast agent affect the signal change in perfusion-weighted magnetic resonance imaging? A computer simulation. Magn Reson Imaging 19:813-820
20. Wenz F, Rempp K, Brix G, Knopp MV, Guckel F, Hess T, van Kaick G (1996) Age dependency of the regional cerebral blood volume (rCBV) measured with dynamic susceptibility contrast MR imaging (DSC).Magn Reson Imaging 14:157-162